---
created: 2025-04-13
updated: 2025-04-13T10:51
id: A<xRWacQ)u
specialty: "[[neuro]]"
specialty_id: 136
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - theme/b&b::14-msk::02-cell-biology::01-skeletal-muscle
  - theme/firstaid::05-pharmacology::03-toxicities-&-side-effects::01-specific-toxicity-treatments
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::13-inhaled-anesthetics
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::13-inhaled-anesthetics::malignant-hyperthermia
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::17-spasmolytics-antispasmodics
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::17-spasmolytics-antispasmodics::dantrolene
  - theme/nbme::18
  - theme/nbme::26
  - source/ome-banner::basic-science::04-general-physiology::10-skeletal-muscle
  - theme/physeo::09-pharm::14-neuro::16-inhaled-anesthetics
  - theme/physeo::09-pharm::14-neuro::19-neuromuscular-blocking-drugs
  - theme/pixorize::02-biochem::20-anesthetics::03-succinylcholine
  - theme/pixorize::03-pharm::12-msk::dantrolene
  - theme/pixorize::03-pharm::14-anesthetics::halothane-and-fluranes
  - theme/pixorize::03-pharm::14-anesthetics::succinylcholine
  - theme/sketchypharm::06-neuro/psych::02-anesthetics-&-analgesics::02-inhaled-anesthetics,-dantrolene
  - theme/uworld::100-999::800-899::855
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::neuro::pharmacology
type: flashcard
---

# Question
Malignant hyperthermia is treated by **dantrolene**, which is a(n) **ryanodine** receptor antagonist that prevents release of Ca2+ from the SR

---

# Answer
